News | Radiation Therapy | August 06, 2020

Radiotherapy Market to Cross $17 Million Revenue by 2030

Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

August 6, 2020 — Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

As per the World Health Organization (WHO), cancer is the second-leading cause of human deaths, killing 9.6 million people annually, at least. Additionally, the American Institute of Cancer Research says that by 2030, around 25 million cases will be diagnosed every year.

Due to the coronavirus pandemic, the radiotherapy market is witnessing subdued growth, as the focus of the healthcare fraternity has shifted from chronic diseases to mitigating the COVID-19 spread. This is why several cancer-specialty hospitals are either shut or have converted to COVID care centers. Moreover, with the uncertain supply chain, the import and export of radiotherapy systems have been hit hard. However, several hospitals are reopening their cancer wards in the present scenario, which is pushing up the number of radiotherapy treatments.

The external beam category, on the basis of type, held the largest share in the radiotherapy market in the past. This technique involves the use of a machine outside the body of the patient, which shoots high-energy X-ray beams at the tumor. With the rising cancer prevalence and research and development (R&D) activities, the usage of external-beam radiotherapy is set to increase further in the coming years.

During the next decade, the fastest growth in the radiotherapy market would be witnessed by the hospitals division, under the end-user segment. This is because of the complexity and critical nature of such treatments, which is why they are performed by trained professionals in hospitals. In addition, as hospitals offer the best possible healthcare services, patients prefer these facilities over others.

North America is the largest radiotherapy market currently, owing to its high incidence of cancer, existence of established radiotherapy system providers, and developed healthcare infrastructure. Further, the disposable income in Canada and the U.S. is quite high, which is why people here are more-easily able to afford the expensive radiotherapy treatments. In the years to come, Asia-Pacific (APAC) is predicted to observe the highest CAGR, on account of the rising number of cancer patients, growing public and private investments, and bettering healthcare infrastructure.

In order to make the most of the increasing radiotherapy market opportunities, companies providing such solutions are engaging in collaborations, partnerships, and other such co-working agreements, with the idea of:

  • Gaining distribution partners for their equipment
  • Offering clinicians a combined solution of image-guided radiotherapy systems and electronic medical record (EMR) platform
  • Developing novel tracers for pre-clinical and clinical neurological and oncologic applications
  • Providing hospitals with advanced proton therapy capabilities
  • Upgrading the motion tracking and correction technologies of their radiotherapy systems

The major players in the global radiotherapy market include Accuray Incorporated, Elekta AB, Becton, Dickinson and Company, Hitachi Ltd., Isoray Inc., Ion Beam Applications SA, Sumitomo Heavy Industries Ltd., Provision Healthcare, ViewRay Inc., Varian Medical Systems Inc., Optivus Proton Therapy Inc., Mevion Medical Systems Inc., P-Cure Ltd., and Panacea Medical Technologies Pvt. Ltd.

For more information: www.psmarketresearch.com

Related Radiotherapy Content:

Image Gallery of New Radiotherapy Technology at AAPM 2019

Find more news and videos from the AAPM meeting

Related Content

Important milestone demonstrates the unrivalled experience, technological innovation and global market leadership of IBA and its clinical partners
News | Proton Therapy | September 25, 2020
September 25, 2020 — IBA (Ion Beam Applications SA) announced that more than 100,000 patients have now been treated w
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...